Manuscripts

Search by keyword, year, or author name.

Showing 1554 manuscripts.

Defining HIV susceptibility to new antiretroviral agents- darunavir

Richard H. Haubrich. Defining HIV susceptibility to new antiretroviral agents- darunavir. Journal of Infectious Diseases. 2007. 196: 1125-7.

Year

2007

Journal

Journal of Infectious Diseases

Long-term persistence of transmitted HIV drug resistance in male genital tract secretions: implications for secondary transmission

Davey M. Smith, Joseph K. Wong, George K. Hightower, Caroline Ignacio, Simon D. W. Frost, Douglas D. Richman, Susan J. Little. Long-term persistence of transmitted HIV drug resistance in male genital tract secretions: implications for secondary transmission. Journal of Infectious Diseases. 2007. 196: 356-60.

Year

2007

Journal

Journal of Infectious Diseases

Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects

C. M. Behler, E. Vittinghoff, F. Lin, Raymond T. Chung, Marion G. Peters, Gregory K. Robbins, Paul Volberding. Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects. Clinical Infectious Diseases. 2007. 44: 1375-83.

Year

2007

Journal

Clinical Infectious Diseases

Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity

G. Gonzalez, Robert Lenkinski, Robert H. Paul, Ronald A. Cohen, Constantin Yiannoutsos, Bradford A. Navia, Eric N. Miller, Linda Chang, Christina M. Marra, Giovanni Schifitto, Thomas Ernst, Elyse J. Singer, Todd Richards, Jeffrey G. Jarvik, Richard W. Price, Dieter J. Meyerhoff, Dennis Kolson, Ronald J. Ellis. Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity. Journal of Neuropsychiatry and Clinical Neurosciences. 2007. 19: 283-92.

Year

2007

Journal

Journal of Neuropsychiatry and Clinical Neurosciences

Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy

Jeff D. Moore, Edward P. Acosta, Victoria A. Johnson, Roland Bassett, Joseph J. Eron, Margaret A. Fischl, Mary C. Long, Daniel R. Kuritzkes, Jean-Pierre Sommadossi. Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy. Antiviral Therapy. 2007. 12: 981-6.

Year

2007

Journal

Antiviral Therapy

Depo-medroxyprogesterone in women on antiretroviral therapy: effective contraception and lack of clinically significant interactions

Susan Ellen Cohn, Jeong-Gun Park, Heather D. Watts, Alice M. Stek, Jane Hitti, Pamela A. Clax, Song Yu, Juan J.L. Lertora. Depo-medroxyprogesterone in women on antiretroviral therapy: effective contraception and lack of clinically significant interactions. Clinical Pharmacology & Therapeutics. 2007. 81: 222-7.

Year

2007

Journal

Clinical Pharmacology & Therapeutics

Viral factors associated with cytokine expression during HCV/HIV co-infection

Jason T. Blackard, Minhee Kang, Benjamin St. Clair, Wenyu Lin, Yoshitaka Kamegaya, Kenneth E. Sherman, Margaret James Koziel, Marion G. Peters, Janet Andersen, Raymond T. Chung. Viral factors associated with cytokine expression during HCV/HIV co-infection. Journal of Interferon and Cytokine Research. 2007. 24: 263-9.

Year

2007

Journal

Journal of Interferon and Cytokine Research

Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA.

Marie Louise Newell, Sharon Huang, Simone Fiore, Claire Thorne, Laurent Mandelbrot, John L. Sullivan, Robert T. Maupin, Issac Delke, Heather D. Watts, Richard D. Gelber, Coleen K. Cunningham. Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA.. BioMed Central Infectious Diseases. 2007. 7: 60. PMID: 17584491

Year

2007

Journal

BioMed Central Infectious Diseases

In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.

Susan Brogly, Nathalie Ylitalo, Lynne M. Mofenson, James M. Oleske, Russell B. Van Dyke, Marilyn Jean Crain, Mark J. Abzug, Michael T. Brady, Patrick Jean-Philippe, Michael Hughes, George Seage. In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.. AIDS. 2007. 21: 929-938. PMID: 17457086

Year

2007

Journal

AIDS

Pharmacokinetics and pharmacodynamics of efavirenz and nelfinavir in HIV-infected children participating in an area-under-the-curve controlled trial.

Courtney V. Fletcher, Richard Brundage, Terence Fenton, Carmelita Alvero, Christine Powell, Lynne M. Mofenson, Stephen A. Spector. Pharmacokinetics and pharmacodynamics of efavirenz and nelfinavir in HIV-infected children participating in an area-under-the-curve controlled trial.. Clinical Pharmacology & Therapeutics. 2007. 83: 300-6. PMID: 17609682

Year

2007

Journal

Clinical Pharmacology & Therapeutics